Login to Your Account

HHS says no thanks to marching in over high drug prices

By Mari Serebrov
Regulatory Editor

Tuesday, March 8, 2016

The U.S. Department of Health and Human Services (HHS) will not issue new guidelines for the NIH to march in on patent rights because of high drug prices. That’s the latest word from HHS Secretary Sylvia Burwell.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription